Next Generation Diagnostics for Rare Neurological Diseases: The Future is Here

Canadian Journal of Neurological Sciences

Volumn 41, Issue 3, 2014, Pages 299-300

  Innes, A Micheil ^a   Boycott, Kym M ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL GENETICS; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; DIAGNOSTIC VALUE; EDITORIAL; GENETIC COUNSELING; HUMAN; INCIDENTAL FINDING; INTELLECTUAL IMPAIRMENT; MEDICAL GENETICS; MOLECULAR DIAGNOSIS; MOLECULAR GENETICS; NEUROLOGIC DISEASE; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; RARE DISEASE; DIAGNOSTIC IMAGING; FORECASTING; GENETIC SCREENING; GENETICS; NERVOUS SYSTEM DISEASES; RARE DISEASES; TRENDS;

DIAGNOSTIC IMAGING; FORECASTING; GENETIC TESTING; HUMANS; NERVOUS SYSTEM DISEASES; RARE DISEASES;

EID: 84976532249     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100017224     Document Type: Editorial

References (14)

1. Canadian Organization for Rare Disorders. Toronto; [cited 2014Feb 20]. Available from: http://www.raredisorders.ca/.
2. McKusick VA. Mendelian inheritance in man and its online version, OMIM. Am J Hum Genet. 2007;80(4):588-604.
3. van Karnebeek C, Murphy T, Giannasi W, Thomas M, Connolly M, Stockler S. Diagnostic value of a multidisciplinary clinic forintellectual disability.Can J Neurol Sci. 2014;41(3):333-45.
4. Duncan AM, Chodirker B. Use of array genomic hybridizationtechnology for constitutional genetic diagnosis in Canada. Paediatr Child Health. 2011;16(4):211-12.
5. Boycott KM, Dyment DA, Sawyer SL, Vanstone MR, Beaulieu CL. Identification of genes for childhood heritable diseases. AnnuRev Med. 2014;65:19-31.
6. de Ligt J, Willemsen MH, van Bon BW, et al. Diagnostic exomesequencing in persons with severe intellectual disability. N EnglJ Med. 2012;367(20):1921-9.
7. Sawyer SL, Schwartzentruber J, Beaulieu CL, et al. Exomesequencing as a diagnostic tool for pediatric-onset ataxia. HumMutat. 2014;35(1):45-9.
8. Shashi V, McConkie-Rosell A, Rosell B, et al. The utility of thetraditional medical genetics diagnostic evaluation in the contextof next-generation sequencing for undiagnosed geneticdisorders. Genet Med. 2013. [EPub ahead of print Aug 8].
9. Green RC, Berg JS, Grody WW, et al. ACMG recommendations forreporting of incidental findings in clinical exome and genomesequencing. Genet Med. 2013;15:565-74.
10. Orphanet Canada. Montreal; [cited 2014 Feb 20]. Available from:http://www.orpha.net/national/CA-EN/index/homepage/.
11. International Rare Disease Research Consortium. Paris; [cited 2014Feb 20]. Available from: http://www.irdirc. org/.
12. Care for Rare Canada. Ottawa; [cited 2014 Feb 20]. Available from:http://www.care4rare.ca.
13. Ku CS, Cooper DN, Polychronakos C, Naidoo N, Wu M, Soong R. Exome sequencing: dual role as a discovery and diagnostic tool. Ann Neurol. 2012;71(1):5-14.
14. PhenomeCentral. Toronto; [cited 2014 Feb 20]. Available from:https://phenomecentral.org.